The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Lokshina A.B.

Grishina D.A.

FGBU Nauchnyĭ tsentr nevrologii RAMN, Moskva

Cavinton Comforte in the correction of vascular cognitive disorders

Authors:

Lokshina A.B., Grishina D.A.

More about the authors

Read: 2527 times


To cite this article:

Lokshina AB, Grishina DA. Cavinton Comforte in the correction of vascular cognitive disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(8):61‑65. (In Russ.)
https://doi.org/10.17116/jnevro201811808161

Recommended articles:
The main mechanisms of deve­lopment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):13-18
Differential diagnosis of Alzheimer’s disease and vascular cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Cognitive impairment after major surgical operations. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):74-80
Prevalence and characteristics of risk factors for cere­brovascular disease in overweight. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):118-124
Features of care of patients with cardiovascular diseases and cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):99-104

References:

  1. Domashenko MA, Maksimova MYu, Popova TA, Tanashyan MM. Current approaches to therapy for chronic forms of cerebrovascular diseases. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2012;4(1):120-123. (In Russ.) https://doi.org/10.14412/2074-2711-2012-375
  2. Esin RG, Esin OR, Khayrullin IKh. Small vessel disease: pathogenic subtypes and possible therapeutic strategies. Consilium Medicum. 2016;18(2):104-108. (In Russ.)
  3. Maksimova MYu, Domashenko MA, Tanashyan MM. Current approaches to preventing and treating chronic cerebral circulatory disorders. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2012;4(4):88-91. (In Russ.) https://doi.org/10.14412/2074-2711-2012-429
  4. Rumyantzeva SA, Sokhova OA, Silina EV. Neuroprotective therapy for chronic cerebral ischemia and ischemic stroke in the rehabilitation period; use of cavinton. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2011;3:80-86. (In Russ.) https://doi.org/10.14412/2074-2711-2011-173
  5. Katunina EA, Belikova LP, Makarova AA. Post-stroke cognitive impairments. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2013;5(2):105-108. (In Russ.) https://doi.org/10.14412/2074-2711-2013-2423
  6. Semak AE, Dymkovskaya MN, Zharko AE, Kozachenok ZhV, Shilov GN. Experience of use and comparative analysis of the effectiveness of drugs Cavinton and Vinpocetin in the treatment of cerebral infarction in the early recovery period. Lechebnoe delo: nauchno-prakticheskij terapevticheskij zhurnal. 2014;5(39):7-14. (In Russ.)
  7. Suslina ZA, Tanashyan MM, Ionova VG, Kistenev BA, Maksimova MYu, Sharypova TN. RMJ. 2002;10(25):1170-1174. (In Russ.)
  8. Chukanova EI. Current aspects of the epidemiology and treatment of chronic brain ischemiain the presence of essential hypertension (results of the CALIPSO program). Nevrologiya, neiropsikhiatriya, psikhosomatika. 2011;3(1):38-42. (In Russ.) https://doi.org/10.14412/2074-2711-2011-132
  9. Tabeeva GR, Azimova YuE. A multimodal strategy of neuroprotection in stroke: results of the Russian multicenter clinical-epidemiological program of SOKOL (Assessment of comparative effectiveness Cavinton and conventional schemes of treatment of patients with acute violation of cerebral circulation). Zhurnal nevrologii i psikhiatrii imeni SS Korsakova. 2012;112(12 Pt 2):20-30. (In Russ.)
  10. Putilina MV, Baranova OA. Results of a multicenter clinical epidemiological observational program «GLOBUS» (the definition of the prevalence of vertigo and the evaluation of therapy regimens on an outpatient basis). Zhurnal nevrologii i psikhiatrii im. SS Korsakova. 2014;(5):33-38. (In Russ.)
  11. Gosudarstvennyi reestr lekarstvennykh sredstv. Instruktsiia po primeneniiu lekarstvennogo preparata dlia meditsinskogo primeneniia Kavinton® Komforte. (In Russ.) https://grls.rosminzdrav.ru/Grls_View_v2.aspx?idReg=143680&t
  12. Tabeeva GR, Kalimeeva EYu, Koberskaya NN, Gereeva SI. Possibilities of therapy for early manifestations of chronic cerebral ischemia: results of the PROFILE program. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2017;9(3):36-41. (In Russ.) https://doi.org/10.14412/2074-2711-2017-3-36-41
  13. Vakhnina NV, Milovanova OV. Neurological disorders in patients with hypertension and their correction. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2016;8(4):32-37. (In Russ.) https://doi.org/10.14412/2074-2711-2016-4-32-37
  14. Zhivolupov SA, Samartsev IN, Yakovlev EV, Butakova YuS, Bodrova TV. Evaluation of the effectiveness of Vinpocetine (Cavinton Comforte) in the treatment of vertigo in patients with dyscirculatory encephalopathy on the level of neurotrophic factor brain (BDNF) in blood plasma. Klinicheskaya farmakologiya i terapiya. 2016;25(1):2-7. (In Russ.)
  15. Belova LA, Mashin VV, Proshin AN, Ovsyannicova AN, Kostishko BB. Possibilities of cavinton therapy regimen for infusions and cavinton comforte in acute and early recovery periods after ischemic stroke. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova. 2017;117(9):51-58. (In Russ.) https://doi.org/10.17116/jnevro20171179151-58
  16. Yakhno NN, Zakharov VV, Koberskaya NN, Mkhitaryan EA, Grishina DA, Lokshina AB, Savushkina IYu, Posokhov SI. Pre-Moderate (Subjective And Mild) Cognitive Disorders. Nevrologicheskiy Zhurnal. 2017;22(4):198-204 (In Russ.) https://doi.org/10.18821/1560-9545-2017-22-4-198-204
  17. Akhutina TV, Melikyan ZA. Neuropsychological assessment: an overview of modern tendencies (dedicated to 110-th anniversary of A.R. Luria). Clinical Psychology and Special Education. 2012;2:1-18. (In Russ.)
  18. Mikadze YuV. Some methodological issues of qualitative and quantitative analysis in neuropsychological diagnosis. Vestnik Moskovskogo universiteta. Seriya. 14. Psihologiya. 2012;2:96-103. (In Russ.)
  19. Semenova OA. Problems of studying executive functions of mental activity in humans. Human Physiology. 2005;31(6):715-723. (In Russ.)
  20. Ashendorf L, Jefferson AL, O’Connor MK, Chaisson C, Green RC, Stern RA. Trail Making Test errors in normal aging, mild cognitive impairment, and dementia. Archives of Clinical Neuropsychology. 2008;23:129-137. https://doi.org/10.1016/j.acn.2007.11.005
  21. Kim HJ, Baek MJ, Kim S. Alternative Type of the Trail Making Test in Nonnative English-Speakers: The Trail Making Test-Black & White. PLoS ONE. 2014;9(2):e89078. https://doi.org/10.1371/journal.pone.0089078
  22. Katz S, Ford AB, Moskpwitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged: The index of ADL, a standardized measure of biological function. JAMA. 1963;185:914-919.
  23. Masur H. Scales and scores in neurology. Quantification of neurological deficits in research and practice. Thieme Stuttgart. 2004.
  24. Sharma S, Deshmukh R. Vinpocetine attenuates MPTP-induced motor deficit and biochemical abnormalities in Wistar rats. Neuroscience. 2015 Feb 12;286:393-403. https://doi.org/10.1016/j.neuroscience.2014.12.008
  25. Shavlovskaya OA. A method of assessing the severity of cognitive-motor disorders in terms of fine motor skills of the hand. Application. Patent for invention. RU 2018123987, 02.07.2018. (In Russ.) Available at: www1.fips.ru

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.